Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.09.2021 | Case report

Gemcitabine

Thrombotic microangiopathy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Murugapandian S, et al. Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations. Case Reports in Nephrology and Dialysis 5: 160-167, No. 2, Jun 2015. Available from: URL: http://doi.org/10.1159/000435807CrossRef Murugapandian S, et al. Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations. Case Reports in Nephrology and Dialysis 5: 160-167, No. 2, Jun 2015. Available from: URL: http://​doi.​org/​10.​1159/​000435807CrossRef
Metadaten
Titel
Gemcitabine
Thrombotic microangiopathy: case report
Publikationsdatum
01.09.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-02143-x

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Tretinoin

Case report

Apixaban

Case report

Levofloxacin

Case report

Itraconazole

Case report

Cotrimoxazole